MYLES B HOWARD
Allopathic & Osteopathic Physicians|Internal Medicine SYRACUSE, NY NPI 1831152941
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Amgen Inc. All categories
General Payments — all program years on this page
$6,159.86
- Category: General Payments
- Program years: PY2018–2024
- Record count: 391
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,497.70 across 83 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,497.70 | 83 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $164.82 | 3 |
| Abbott Laboratories | $159.27 | 14 |
| GlaxoSmithKline, LLC. | $157.75 | 9 |
| SHIELD THERAPEUTICS INC | $148.46 | 10 |
| Lilly USA, LLC | $128.82 | 7 |
| Gilead Sciences, Inc. | $111.72 | 5 |
| Merck Sharp & Dohme Corporation | $78.57 | 4 |
| Exact Sciences Corporation | $68.97 | 4 |
| Novo Nordisk AS | $67.56 | 4 |
| Janssen Pharmaceuticals, Inc | $64.60 | 3 |
| PFIZER INC. | $60.17 | 4 |
| Otsuka America Pharmaceutical, Inc. | $55.89 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $55.13 | 3 |
| Astellas Pharma US Inc | $36.42 | 2 |
| Orexo US, Inc. | $31.25 | 2 |
| Alkermes, Inc. | $21.54 | 1 |
| Indivior Inc. | $21.33 | 1 |
| Mylan Specialty L.P. | $18.40 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $18.12 | 1 |
| Braeburn Inc. | $14.59 | 1 |
| ABBVIE INC. | $14.32 | 1 |
By program year
Records — PY2024 (83)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.